Induced pluripotent stem cells in cartilage tissue engineering: A Literature Review

Amani Y. Owaidah,Amani Yousef Owaidah

DOI: https://doi.org/10.1042/bsr20232102

2024-04-03

Bioscience Reports

Abstract:CONCLUSIONS: This review has provided a comprehensive overview of these technologies and the potential applications for hiPSCs in regenerative medicine.

cell biology,biochemistry & molecular biology

What problem does this paper attempt to address?

Cartilage Repair Using Hyaluronan Hydrogel-Encapsulated Human Embryonic Stem Cell-Derived Chondrogenic Cells

Wei Seong Toh,Eng Hin Lee,Xi-Min Guo,Jerry K. Y. Chan,Chen Hua Yeow,Andre B. Choo,Tong Cao

DOI: https://doi.org/10.1016/j.biomaterials.2010.05.064

IF: 14

2010-01-01

Biomaterials

Abstract:Human embryonic stem cells (hESCs) have the potential to offer a virtually unlimited source of chondrogenic cells for use in cartilage repair and regeneration. We have recently shown that expandable chondrogenic cells can be derived from hESCs under selective growth factor-responsive conditions. In this study, we explore the potential of these hESC-derived chondrogenic cells to produce an extracellular matrix (ECM)-enriched cartilaginous tissue construct when cultured in hyaluronic acid (HA)-based hydrogel, and further investigated the long-term reparative ability of the resulting hESC-derived chondrogenic cell-engineered cartilage (HCCEC) in an osteochondral defect model. We hypothesized that HCCEC can provide a functional template capable of undergoing orderly remodeling during the repair of critical-sized osteochondral defects (1.5 mm in diameter, 1 mm depth into the subchondral bone) in a rat model. In the process of repair, we observed an orderly spatial-temporal remodeling of HCCEC over 12 weeks into osteochondral tissue, with characteristic architectural features including a hyaline-like neocartilage layer with good surface regularity and complete integration with the adjacent host cartilage and a regenerated subchondral bone. By 12 weeks, the HCCEC-regenerated osteochondral tissue resembled closely that of age-matched unoperated native control, while only fibrous tissue filled in the control defects which left empty or treated with hydrogel alone. Here we demonstrate that transplanted hESC-derived chondrogenic cells maintain long-term viability with no evidence of tumorigenicity, providing a safe, highly-efficient and practical strategy of applying hESCs for cartilage tissue engineering.
Induced pluripotent stem cells for cartilage repair: current status and future perspectives

R Castro-Viñuelas,C Sanjurjo-Rodríguez,M Piñeiro-Ramil,T Hermida-Gómez,I M Fuentes-Boquete,F J de Toro-Santos,F J Blanco-García,S M Díaz-Prado

DOI: https://doi.org/10.22203/eCM.v036a08

2018-09-11

Abstract:The establishment of cartilage regenerative medicine is an important clinical issue, but the search for cell sources able to restore cartilage integrity proves to be challenging. Human mesenchymal stromal cells (MSCs) are prone to form epiphyseal or hypertrophic cartilage and have an age-related limited proliferation. On the other hand, it is difficult to obtain functional chondrocytes from human embryonic stem cells (ESCs). Moreover, the ethical issues associated with human ESCs are an additional disadvantage of using such cells. Since their discovery in 2006, induced pluripotent stems cells (iPSCs) have opened many gateways to regenerative medicine research, especially in cartilage tissue engineering therapies. iPSCs have the capacity to overcome limitations associated with current cell sources since large numbers of autologous cells can be derived from small starting populations. Moreover, problems associated with epiphyseal or hypertrophic-cartilage formation can be overcome using iPSCs. iPSCs emerge as a promising cell source for treating cartilage defects and have the potential to be used in the clinical field. For this purpose, robust protocols to induce chondrogenesis, both in vitro an in vivo, are required. This review summarises the recent progress in iPSC technology and its applications for cartilage repair.
The Potency of Induced Pluripotent Stem Cell as a New Promising Treatment Regeneration: A Systematic Review

Astuti Setyawardani,Johan Bastian

DOI: https://doi.org/10.1177/2325967124s00405

IF: 2.6

2024-10-25

Orthopaedic Journal of Sports Medicine

Abstract:Orthopaedic Journal of Sports Medicine, Volume 12, Issue 10_suppl3, October 2024. Introduction and Objective:Articular cartilage has a restricted capacity for self-regeneration when injured through trauma or disease. The inability to treat focal chondral lesions results in changes that inevitably progress to osteoarthritis. Lately, there have been many developments in the use of cell-based regenerative therapies for cartilage defects. The improvement of regenerative treatments for cartilage injury has been enormously supported by recent advances in stem cell biology. Some potential cell-based regenerative therapies include chondrocytes, multipotent stem cells (e.g. multipotent stem cells [MSCs]), and pluripotent stem cells (e.g. embryonic stem cells [ESCs]). All of these developments are mostly successful but have some limitations such as ethical issues and the potential for immunogenic or teratoma formation. Induced pluripotent stem cell (iPSC) has the potential to provide a prosperous cell source for tissue engineering, as well as produce patient-matched in vitro model study genetics and environmental factor in cartilage regeneration and prevent osteoarthritis. This systematic review aimed to investigate the potency of iPSC for cartilage regeneration through in vivo models.Material and Methods:Up until July 2023, multiple electronic databases (PubMed, Google Scholar, and Science Direct) were searched. Original research articles or research reports were included. Review, case report, case series, and conference abstract were excluded. Articles with full-text unavailability, non-English, and irrelevant topics were also excluded. The included studies were assessed for risk of bias using the systematic review center for laboratory animal experimentation (SYRCLE)Results:A total of 1072 studies were recorded from all databases. Amongst them, five studies, all original research articles, were eligible for qualitative synthesis. All of these articles show that iPSCs have the potential to produce high-quality cartilage regeneration which can successfully repair cartilage defects in vivo studies. Furthermore, no abnormal proliferation or teratoma was detected.Conclusion:The use of iPSC could be a new promising treatment in the use of cell-based regenerative therapies with unlimited pluripotent tissue regeneration with minimally ethical issues. In addition, further research related to clinical trials, dosage, method of administration, and long-term side effects are still needed further

orthopedics,sport sciences
Potential of Human Embryonic Stem Cells in Cartilage Tissue Engineering and Regenerative Medicine

Wei Seong Toh,Eng Hin Lee,Tong Cao

DOI: https://doi.org/10.1007/s12015-010-9222-6

2010-12-29

Stem Cell Reviews and Reports

Abstract:The current surgical intervention of using autologous chondrocyte implantation (ACI) for cartilage repair is associated with several problems such as donor site morbidity, de-differentiation upon expansion and fibrocartilage repair following transplantation. This has led to exploration of the use of stem cells as a model for chondrogenic differentiation as well as a potential source of chondrogenic cells for cartilage tissue engineering and repair. Embryonic stem cells (ESCs) are advantageous, due to their unlimited self-renewal and pluripotency, thus representing an immortal cell source that could potentially provide an unlimited supply of chondrogenic cells for both cell and tissue-based therapies and replacements. This review aims to present an overview of emerging trends of using ESCs in cartilage tissue engineering and regenerative medicine. In particular, we will be focusing on ESCs as a promising cell source for cartilage regeneration, the various strategies and approaches employed in chondrogenic differentiation and tissue engineering, the associated outcomes from animal studies, and the challenges that need to be overcome before clinical application is possible.

cell biology,medicine, research & experimental,cell & tissue engineering
iPSCs chondrogenic differentiation for personalized regenerative medicine: a literature review

Eltahir Abdelrazig Mohamed Ali,Rana Smaida,Morgane Meyer,Wenxin Ou,Zongjin Li,Zhongchao Han,Nadia Benkirane-Jessel,Jacques Eric Gottenberg,Guoqiang Hua

DOI: https://doi.org/10.1186/s13287-024-03794-1

2024-06-26

Abstract:Cartilage, an important connective tissue, provides structural support to other body tissues, and serves as a cushion against impacts throughout the body. Found at the end of the bones, cartilage decreases friction and averts bone-on-bone contact during joint movement. Therefore, defects of cartilage can result from natural wear and tear, or from traumatic events, such as injuries or sudden changes in direction during sports activities. Overtime, these cartilage defects which do not always produce immediate symptoms, could lead to severe clinical pathologies. The emergence of induced pluripotent stem cells (iPSCs) has revolutionized the field of regenerative medicine, providing a promising platform for generating various cell types for therapeutic applications. Thus, chondrocytes differentiated from iPSCs become a promising avenue for non-invasive clinical interventions for cartilage injuries and diseases. In this review, we aim to highlight the current strategies used for in vitro chondrogenic differentiation of iPSCs and to explore their multifaceted applications in disease modeling, drug screening, and personalized regenerative medicine. Achieving abundant functional iPSC-derived chondrocytes requires optimization of culture conditions, incorporating specific growth factors, and precise temporal control. Continual improvements in differentiation methods and integration of emerging genome editing, organoids, and 3D bioprinting technologies will enhance the translational applications of iPSC-derived chondrocytes. Finally, to unlock the benefits for patients suffering from cartilage diseases through iPSCs-derived technologies in chondrogenesis, automatic cell therapy manufacturing systems will not only reduce human intervention and ensure sterile processes within isolator-like platforms to minimize contamination risks, but also provide customized production processes with enhanced scalability and efficiency.
Considerations in hiPSC-derived cartilage for articular cartilage repair

Akihiro Yamashita,Yoshihiro Tamamura,Miho Morioka,Peter Karagiannis,Nobuyuki Shima,Noriyuki Tsumaki

DOI: https://doi.org/10.1186/s41232-018-0075-8

2018-10-04

Inflammation and Regeneration

Abstract:BackgroundA lack of cell or tissue sources hampers regenerative medicine for articular cartilage damage.Main textWe review and discuss the possible use of pluripotent stem cells as a new source for future clinical use. Human induced pluripotent stem cells (hiPSCs) have several advantages over human embryonic stem cells (hESCs). Methods for the generation of chondrocytes and cartilage from hiPSCs have been developed. To reduce the cost of this regenerative medicine, allogeneic transplantation is preferable. hiPSC-derived cartilage shows low immunogenicity like native cartilage, because the cartilage is avascular and chondrocytes are segregated by the extracellular matrix. In addition, we consider our experience with the aberrant deposition of lipofuscin or melanin on cartilage during the chondrogenic differentiation of hiPSCs.Short conclusionCartilage generated from allogeneic hiPSC-derived cartilage can be used to repair articular cartilage damage.

immunology,medicine, research & experimental
Reprogramming of blood cells into induced pluripotent stem cells as a new cell source for cartilage repair

Yueying Li,Tie Liu,Nicholas Van Halm-Lutterodt,JiaYu Chen,Qingjun Su,Yong Hai

DOI: https://doi.org/10.1186/s13287-016-0290-7

2016-02-17

Abstract:Abstract Background An attempt was made to reprogram peripheral blood cells into human induced pluripotent stem cell (hiPSCs) as a new cell source for cartilage repair. Methods We generated chondrogenic lineage from human peripheral blood via hiPSCs using an integration-free method. Peripheral blood cells were either obtained from a human blood bank or freshly collected from volunteers. After transforming peripheral blood cells into iPSCs, the newly derived iPSCs were further characterized through karyotype analysis, pluripotency gene expression and cell differentiation ability. iPSCs were differentiated through multiple steps, including embryoid body formation, hiPSC-mesenchymal stem cell (MSC)-like cell expansion, and chondrogenic induction for 21 days. Chondrocyte phenotype was then assessed by morphological, histological and biochemical analysis, as well as the chondrogenic expression. Results hiPSCs derived from peripheral blood cells were successfully generated, and were characterized by fluorescent immunostaining of pluripotent markers and teratoma formation in vivo. Flow cytometric analysis showed that MSC markers CD73 and CD105 were present in monolayer cultured hiPSC–MSC-like cells. Both alcian blue and toluidine blue staining of hiPSC–MSC-chondrogenic pellets showed as positive. Immunohistochemistry of collagen II and X staining of the pellets were also positive. The sulfated glycosaminoglycan content was significantly increased, and the expression levels of the chondrogenic markers COL2 , COL10, COL9 and AGGRECAN were significantly higher in chondrogenic pellets than in undifferentiated cells. These results indicated that peripheral blood cells could be a potential source for differentiation into chondrogenic lineage in vitro via generation of mesenchymal progenitor cells. Conclusions This study supports the potential applications of utilizing peripheral blood cells in generating seed cells for cartilage regenerative medicine in a patient-specific and cost-effective approach.

cell biology,medicine, research & experimental,cell & tissue engineering
Advances in cartilage tissue regeneration: a review of stem cell therapies, tissue engineering, biomaterials, and clinical trials

Julia Skoracka,Kaja Bajewska,Maciej Kulawik,Wiktoria Suchorska,Katarzyna Kulcenty

DOI: https://doi.org/10.17179/excli2024-7088

2024-09-03

Abstract:Cartilage tissue, characterized by its limited regenerative capacity, presents significant challenges in clinical therapy. Recent advancements in cartilage regeneration have focused on integrating stem cell therapies, tissue engineering strategies, and advanced modeling techniques to overcome existing limitations. Stem cells, particularly Mesenchymal Stem Cells (MSCs) and induced pluripotent stem cells (iPSCs), hold promise for cartilage repair due to their ability to differentiate into chondrocytes, the key cells responsible for cartilage formation. Tissue engineering approaches, including 3D models, organ-on-a-chip systems, and organoids, offer innovative methods to mimic natural tissue microenvironments and evaluate potential treatments. MSC-based techniques, such as cell sheet tissue engineering, address challenges associated with traditional therapies, including cell availability and culture difficulties. Furthermore, advancements in 3D bioprinting enable the fabrication of complex tissue structures, while organ-on-a-chip systems provide microfluidic platforms for disease modeling and physiological mimicry. Organoids serve as simplified models of organs, capturing some complexity and enabling the monitoring of pathophysiological aspects of cartilage diseases. This comprehensive review underscores the transformative potential of integrating stem cell therapies, tissue engineering strategies, and advanced modeling techniques to improve cartilage regeneration and pave the way for more effective clinical treatments.
Induced pluripotent stem cells as a new getaway for bone tissue engineering: A systematic review

Farshid Bastami,Pantea Nazeman,Hamidreza Moslemi,Maryam Rezai Rad,Kazem Sharifi,Arash Khojasteh

DOI: https://doi.org/10.1111/cpr.12321

Abstract:Objectives: Mesenchymal stem cells (MSCs) are frequently used for bone regeneration, however, they are limited in quantity. Moreover, their proliferation and differentiation capabilities reduce during cell culture expansion. Potential application of induced pluripotent stem cells (iPSCs) has been reported as a promising alternative source for bone regeneration. This study aimed to systematically review the available literature on osteogenic potential of iPSCs and to discuss methods applied to enhance their osteogenic potential. Methods and materials: A thorough search of MEDLINE database was performed from January 2006 to September 2016, limited to English-language articles. All in vitro and in vivo studies on application of iPSCs in bone regeneration were included. Results: The current review is organized according to the PRISMA statement. Studies were categorized according to three different approaches used for osteo-induction of iPSCs. Data are summarized and reported according to the following variables: types of study, cell sources used for iPSC generation, applied reprogramming methods, applied osteo-induction methods and treatment groups. Conclusion: According to the articles reviewed, osteo-induced iPSCs revealed osteogenic capability equal to or superior than MSCs; cell sources do not significantly affect osteogenic potential of iPSCs; addition of resveratrol to the osteogenic medium (OM) and irradiatiation after osteogenic induction reduce teratoma formation in animal models; transfection with lentiviral bone morphogenetic protein 2 results in higher mineralization compared to osteo-induction in OM; addition of TGF-β, IGF-1 and FGF-β to OM increases osteogenic capability of iPSCs.
In Vivo Repair of Full-Thickness Cartilage Defect with Human Ipsc-Derived Mesenchymal Progenitor Cells in a Rabbit Model.

Xingquan Xu,Dongquan Shi,Yubao Liu,Yao,Jin Dai,Zhihong Xu,Dongyang Chen,Huajian Teng,Qing Jiang

DOI: https://doi.org/10.3892/etm.2017.4474

IF: 2.7

2017-01-01

Experimental and Therapeutic Medicine

Abstract:Cell-based tissue engineering has the potential to restore cartilage defects. Induced pluripotent stem cells (iPSCs) are regarded as an alternative cell source in regenerative medicine. The purpose of the present study was to evaluate the use of mesenchymal stem cells (MSCs) derived from human iPSCs (hiPSCs) for the regeneration of cartilage defects in a rabbit model. Cartilage defects were made in the patellar grooves of New Zealand white rabbits. The rabbits were then divided into three groups according to implantation: Control group, scaffold implantation group and scaffold/hiPSCs-MSCs (experimental) group. MSCs were generated from hiPSCs via a step of embryoid body formation. Following flow cytological analysis, the hiPSCs-MSCs were plated onto poly(lactic-co-glycolide) and then transplanted into the cartilage defects in the experimental group. Six rabbits from each group were sacrificed at each time point. The outcome was assessed macroscopically and histologically at 3 and 6 weeks post-surgery. At 3 and 6 weeks, the experimental group showed more cartilage defect filling compared with the control and scaffold implantation groups. At 3 weeks, the experimental group showed much more repair tissue in the cartilage defect, although no cartilage-like tissue was observed. At 6 weeks, cartilage-like tissue was observed in the experimental group but not in the control or scaffold implantation groups. No teratoma formation was observed in any of the groups. The results indicate that iPSCs have the potential to repair cartilage defects in vivo. Therefore, iPSCs could be a new cell source for cartilage defect repair.
The Use of Infrapatellar Fat Pad-Derived Mesenchymal Stem Cells in Articular Cartilage Regeneration: A Review

Parviz Vahedi,Rana Moghaddamshahabi,Thomas J Webster,Ayse Ceren Calikoglu Koyuncu,Elham Ahmadian,Wasim S Khan,Ali Jimale Mohamed,Aziz Eftekhari

DOI: https://doi.org/10.3390/ijms22179215

2021-08-26

Abstract:Cartilage is frequently damaged with a limited capacity for repair. Current treatment strategies are insufficient as they form fibrocartilage as opposed to hyaline cartilage, and do not prevent the progression of degenerative changes. There is increasing interest in the use of autologous mesenchymal stem cells (MSC) for tissue regeneration. MSCs that are used to treat articular cartilage defects must not only present a robust cartilaginous production capacity, but they also must not cause morbidity at the harvest site. In addition, they should be easy to isolate from the tissue and expand in culture without terminal differentiation. The source of MSCs is one of the most important factors that may affect treatment. The infrapatellar fat pad (IPFP) acts as an important reservoir for MSC and is located in the anterior compartment of the knee joint in the extra-synovial area. The IPFP is a rich source of MSCs, and in this review, we discuss studies that demonstrate that these cells have shown many advantages over other tissues in terms of ease of isolation, expansion, and chondrogenic differentiation. Future studies in articular cartilage repair strategies and suitable extraction as well as cell culture methods will extend the therapeutical application of IPFP-derived MSCs into additional orthopedic fields, such as osteoarthritis. This review provides the latest research concerning the use of IPFP-derived MSCs in the treatment of articular cartilage damage, providing critical information for the field to grow.
The Research Status of Induced Pluripotent Stem Cells

WANG Yingjie,LIU Tao,ZHANG Shichang

DOI: https://doi.org/10.3969/j.issn.1006-5709.2009.09.001

2009-01-01

Abstract:Induced pluripotent stem cells(iPSc) are a type of pluripotent stem cells artificially derived from an adult somatic cells,by inducing a forced expression of certain genes.They can easily be generated,proliferate unlimited while maintaining the capacity of multilineage differentiation.We presented a review here about the methods of generating iPSc,application prospects and the outlook of applications in the field of liver diseases.
Advanced Hydrogels for Cartilage Tissue Engineering: Recent Progress and Future Directions

Mahshid Hafezi,Saied Nouri Khorasani,Mohadeseh Zare,Rasoul Esmaeely Neisiany,Pooya Davoodi

DOI: https://doi.org/10.3390/polym13234199

IF: 5

2021-11-30

Polymers

Abstract:Cartilage is a tension- and load-bearing tissue and has a limited capacity for intrinsic self-healing. While microfracture and arthroplasty are the conventional methods for cartilage repair, these methods are unable to completely heal the damaged tissue. The need to overcome the restrictions of these therapies for cartilage regeneration has expanded the field of cartilage tissue engineering (CTE), in which novel engineering and biological approaches are introduced to accelerate the development of new biomimetic cartilage to replace the injured tissue. Until now, a wide range of hydrogels and cell sources have been employed for CTE to either recapitulate microenvironmental cues during a new tissue growth or to compel the recovery of cartilaginous structures via manipulating biochemical and biomechanical properties of the original tissue. Towards modifying current cartilage treatments, advanced hydrogels have been designed and synthesized in recent years to improve network crosslinking and self-recovery of implanted scaffolds after damage in vivo. This review focused on the recent advances in CTE, especially self-healing hydrogels. The article firstly presents the cartilage tissue, its defects, and treatments. Subsequently, introduces CTE and summarizes the polymeric hydrogels and their advances. Furthermore, characterizations, the advantages, and disadvantages of advanced hydrogels such as multi-materials, IPNs, nanomaterials, and supramolecular are discussed. Afterward, the self-healing hydrogels in CTE, mechanisms, and the physical and chemical methods for the synthesis of such hydrogels for improving the reformation of CTE are introduced. The article then briefly describes the fabrication methods in CTE. Finally, this review presents a conclusion of prevalent challenges and future outlooks for self-healing hydrogels in CTE applications.

polymer science
Narrative review of the choices of stem cell sources and hydrogels for cartilage tissue engineering

Zhantao Deng,Jiewen Jin,Shuai Wang,Fangjie Qi,Xuepan Chen,Chang Liu,Yanbing Li,Yuanchen Ma,Fengjuan Lyu,Qiujian Zheng

DOI: https://doi.org/10.21037/atm-20-2342

IF: 3.616

2020-12-01

Annals of Translational Medicine

Abstract:Stem cell-based therapy is a promising treatment for cartilage defects due to the pluripotency, abundant sources and low immunogenicity of stem cells. Hydrogels are a promising class of biomaterials for cartilage engineering and are characterized by bioactivity, degradability and elasticity as well as provide water content and mechanical support. The combination of stem cells and hydrogels opens new possibilities for cartilage tissue engineering. However, the selection of suitable types of stem cells and hydrogels is difficult. Currently, various types of stem cells, such as embryonic stem cells (ESCs), mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), and peripheral blood mononuclear cells (PBMSCs), and various types of hydrogels, including natural polymers, chemically modified natural polymers and synthetic polymers, have been explored based on their potential for cartilage tissue engineering. These materials are used independently or in combination; however, there is no clear understanding of their merits and disadvantages with regard to their suitability for cartilage repair. In this article, we aim to review recent progress in the use of stem cell-hydrogel hybrid constructs for cartilage tissue engineering. We focus on the effects of stem cell types and hydrogel types on efficient chondrogenesis from cellular, preclinical and clinical perspectives. We compare and analyze the advantages and disadvantages of these cells and hydrogels with the hope of increasing discussion of their suitability for cartilage repair and present our perspective on their use for the improvement of physical and biological properties for cartilage tissue engineering.

oncology,medicine, research & experimental
Rejuvenated Stem/Progenitor Cells for Cartilage Repair Using the Pluripotent Stem Cell Technology

Naoki Nakayama,Sudheer Ravuri,Johnny Huard

DOI: https://doi.org/10.3390/bioengineering8040046

2021-04-10

Abstract:It is widely accepted that chondral defects in articular cartilage of adult joints are never repaired spontaneously, which is considered to be one of the major causes of age-related degenerative joint disorders, such as osteoarthritis. Since mobilization of subchondral bone (marrow) cells and addition of chondrocytes or mesenchymal stromal cells into full-thickness defects show some degrees of repair, the lack of self-repair activity in adult articular cartilage can be attributed to lack of reparative cells in adult joints. In contrast, during a fetal or embryonic stage, joint articular cartilage has a scar-less repair activity, suggesting that embryonic joints may contain cells responsible for such activity, which can be chondrocytes, chondroprogenitors, or other cell types such as skeletal stem cells. In this respect, the tendency of pluripotent stem cells (PSCs) to give rise to cells of embryonic characteristics will provide opportunity, especially for humans, to obtain cells carrying similar cartilage self-repair activity. Making use of PSC-derived cells for cartilage repair is still in a basic or preclinical research phase. This review will provide brief overviews on how human PSCs have been used for cartilage repair studies.
Effective repair of articular cartilage using human pluripotent stem cell-derived tissue

O F Gardner,S C Juneja,H Whetstone,Y Nartiss,J T Sieker,C Veillette,G M Keller,A M Craft

DOI: https://doi.org/10.22203/eCM.v038a15

2019-11-05

Abstract:In an effort to develop an effective source of clinically relevant cells and tissues for cartilage repair a directed differentiation method was used to generate articular chondrocytes and cartilage tissues from human embryonic stem cells (hESCs). It has previously been demonstrated that chondrocytes derived from hESCs retain a stable cartilage-forming phenotype following subcutaneous implantation in mice. In this report, the potential of hESC-derived articular-like cartilage to repair osteochondral defects created in the rat trochlea was evaluated. Articular cartilage-like tissues were generated from hESCs and implanted into the defects. After 6 and 12 weeks, the defects were evaluated histologically and immunohistochemically, and the quality of repair was assessed using a modified ICRS II scoring system. Following 6 and 12 weeks after implantation, hESC-derived cartilage tissues maintained their proteoglycan and type II collagen-rich matrix and scored significantly higher than control defects, which had been filled with fibrin glue alone. Implants were found to be well integrated with native host tissue at the basal and lateral surfaces, although implanted human cells and host cells remained regionally separated. A subset of implants underwent a process of remodeling similar to endochondral ossification, suggesting the potential for a single cartilaginous implant to promote the generation of new subchondral bone in addition to repair of the articular cartilage. The ability to create cartilage tissues with integrative and reparative properties from an unlimited and robust cell source represents a significant advance for cartilage repair that can be further developed in large animal models before clinical- setting application.
Treatment and application of stem cells from different sources for cartilage injury: a literature review

Pengzhen Wang,Shaoheng Zhang,Qingqi Meng,Pingping Zhu,Wei Yuan

DOI: https://doi.org/10.21037/atm-22-1715

IF: 3.616

2022-05-20

Annals of Translational Medicine

Abstract:Background and Objective: Cartilage defects and degeneration have a major impact on daily mobility and quality of life for millions of people worldwide. As the most effective seed cells for tissue engineering applications in regenerative medicine, mesenchymal stem cells (MSCs) are pluripotent cells with mesoderm and neural crest origin. The combination of biomaterial scaffolds with stem cells and drugs for cartilage damage repair has brought much hope to the medical field.Methods: We searched and compared the literature on cartilage damage repaired by stem cells through PubMed and Web of Science method, this review summarizes the research progress of mesenchymal stem cells from various tissue sources in repairing articular cartilage injury.Key Content and Findings: We found that peripheral blood, bone marrow, umbilical cord blood, adipose tissue, and umbilical cord are classic stem cell sources. Stem cells can be stimulated by various growth factors, recombinant proteins, or important monomers to generate cartilage in vitro. At the same time, MSCs obtained from various sources can secrete different growth factors to further regulate their own cartilage formation. These stem cells may promote the cartilage damage repair by promoting differentiation and fighting inflammation.Conclusions: This review summarizes and discusses the advantages and disadvantages of the ability of MSCs from different sources to treat cartilage injury, and provides help and identification for the subsequent in-depth research and preclinical application of various MSCs.

oncology,medicine, research & experimental
Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration

Yoojun Nam,Yeri Alice Rim,Seung Min Jung,Ji Hyeon Ju

DOI: https://doi.org/10.1186/s13287-017-0477-6

2017-01-28

Abstract:BackgroundThe native articular cartilage lacks the ability to heal. Currently, ex vivo expanded chondrocytes or bone marrow-derived mesenchymal stem cells are used to regenerate the damaged cartilage. With unlimited self-renewal ability and multipotency, human induced pluripotent stem cells (hiPSCs) have been highlighted as a new replacement cell source for cartilage repair. Still, further research is needed on cartilage regeneration using cord blood mononuclear cell-derived hiPSCs (CBMC-hiPSCs).MethodsHuman iPSCs were generated from CBMCs using the Sendai virus. The characterization of CBMC-hiPSCs was performed by various assays. Embryonic bodies (EBs) were obtained using CBMC-hiPSCs, and outgrowth cells were induced by plating the EBs onto a gelatin-coated plate. Expanded outgrowth cells were detached and dissociated for chondrogenic differentiation. Outgrowth cells were differentiated into chondrogenic lineage with pellet culture. Chondrogenic pellets were maintained for 30 days. The quality of chondrogenic pellets was evaluated using various staining and genetic analysis of cartilage-specific markers.ResultsReprogramming was successfully done using CBMCs. CBMC-hiPSCs (n = 3) showed high pluripotency and normal karyotype. Chondrogenic pellets were generated from the outgrowth cells derived from CBMC-hiPSC EBs. The generated chondrogenic pellets showed high expression of chondrogenic genetic markers such as ACAN, COMP, COL2A1, and SOX9. The production of extracellular matrix (ECM) proteins was confirmed by safranin O, alcian blue and toluidine blue staining. Expression of collagen type II and aggrecan was detected in the accumulated ECM by immunohistological staining. Chondrogenic pellets showed low expression of fibrotic and hypertrophic cartilage marker, collagen type I and X.ConclusionsThis study reveals the potential of CBMC-hiPSCs as a promising candidate for cartilage regeneration.

cell biology,medicine, research & experimental,cell & tissue engineering
Human pluripotent stem cell-derived chondroprogenitors for cartilage tissue engineering

Naoki Nakayama,Azim Pothiawala,John Y Lee,Nadine Matthias,Katsutsugu Umeda,Bryan K Ang,Johnny Huard,Yun Huang,Deqiang Sun

DOI: https://doi.org/10.1007/s00018-019-03445-2

Abstract:The cartilage of joints, such as meniscus and articular cartilage, is normally long lasting (i.e., permanent). However, once damaged, especially in large animals and humans, joint cartilage is not spontaneously repaired. Compensating the lack of repair activity by supplying cartilage-(re)forming cells, such as chondrocytes or mesenchymal stromal cells, or by transplanting a piece of normal cartilage, has been the basis of therapy for biological restoration of damaged joint cartilage. Unfortunately, current biological therapies face problems on a number of fronts. The joint cartilage is generated de novo from a specialized cell type, termed a 'joint progenitor' or 'interzone cell' during embryogenesis. Therefore, embryonic chondroprogenitors that mimic the property of joint progenitors might be the best type of cell for regenerating joint cartilage in the adult. Pluripotent stem cells (PSCs) are expected to differentiate in culture into any somatic cell type through processes that mimic embryogenesis, making human (h)PSCs a promising source of embryonic chondroprogenitors. The major research goals toward the clinical application of PSCs in joint cartilage regeneration are to (1) efficiently generate lineage-specific chondroprogenitors from hPSCs, (2) expand the chondroprogenitors to the number needed for therapy without loss of their chondrogenic activity, and (3) direct the in vivo or in vitro differentiation of the chondroprogenitors to articular or meniscal (i.e., permanent) chondrocytes rather than growth plate (i.e., transient) chondrocytes. This review is aimed at providing the current state of research toward meeting these goals. We also include our recent achievement of successful generation of "permanent-like" cartilage from long-term expandable, hPSC-derived ectomesenchymal chondroprogenitors.
Repair of cartilage defects in osteoarthritis rats with induced pluripotent stem cell derived chondrocytes

Yanxia Zhu,Xiaomin Wu,Yuhong Liang,Hongsheng Gu,Kedong Song,Xuenong Zou,Guangqian Zhou

DOI: https://doi.org/10.1186/s12896-016-0306-5

2016-11-09

BMC Biotechnology

Abstract:BackgroundThe incapacity of articular cartilage (AC) for self-repair after damage ultimately leads to the development of osteoarthritis. Stem cell-based therapy has been proposed for the treatment of osteoarthritis (OA) and induced pluripotent stem cells (iPSCs) are becoming a promising stem cell source.ResultsThree steps were developed to differentiate human iPSCs into chondrocytes which were transplanted into rat OA models induced by monosodium iodoacetate (MIA). After 6 days embryonic body (EB) formation and 2 weeks differentiation, the gene and protein expression of Col2A1, GAG and Sox9 has significantly increased compare to undifferentiated hiPSCs. After 15 weeks transplantation, no immune responses were observed, micro-CT showed gradual engraftment and the improvement of subchondrol plate integrity, and histological examinations demonstrated articular cartilage matrix production.ConclusionshiPSC could be an efficient and clinically translatable approach for cartilage tissue regeneration in OA cartilages.

biotechnology & applied microbiology

Induced pluripotent stem cells in cartilage tissue engineering: A Literature Review

Cartilage Repair Using Hyaluronan Hydrogel-Encapsulated Human Embryonic Stem Cell-Derived Chondrogenic Cells

Induced pluripotent stem cells for cartilage repair: current status and future perspectives

The Potency of Induced Pluripotent Stem Cell as a New Promising Treatment Regeneration: A Systematic Review

Potential of Human Embryonic Stem Cells in Cartilage Tissue Engineering and Regenerative Medicine

iPSCs chondrogenic differentiation for personalized regenerative medicine: a literature review

Considerations in hiPSC-derived cartilage for articular cartilage repair

Reprogramming of blood cells into induced pluripotent stem cells as a new cell source for cartilage repair

Advances in cartilage tissue regeneration: a review of stem cell therapies, tissue engineering, biomaterials, and clinical trials

Induced pluripotent stem cells as a new getaway for bone tissue engineering: A systematic review

In Vivo Repair of Full-Thickness Cartilage Defect with Human Ipsc-Derived Mesenchymal Progenitor Cells in a Rabbit Model.

The Use of Infrapatellar Fat Pad-Derived Mesenchymal Stem Cells in Articular Cartilage Regeneration: A Review

The Research Status of Induced Pluripotent Stem Cells

Advanced Hydrogels for Cartilage Tissue Engineering: Recent Progress and Future Directions

Narrative review of the choices of stem cell sources and hydrogels for cartilage tissue engineering

Rejuvenated Stem/Progenitor Cells for Cartilage Repair Using the Pluripotent Stem Cell Technology

Effective repair of articular cartilage using human pluripotent stem cell-derived tissue

Treatment and application of stem cells from different sources for cartilage injury: a literature review

Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration

Human pluripotent stem cell-derived chondroprogenitors for cartilage tissue engineering

Repair of cartilage defects in osteoarthritis rats with induced pluripotent stem cell derived chondrocytes